GB202106412D0 - Distributing microparticles - Google Patents

Distributing microparticles

Info

Publication number
GB202106412D0
GB202106412D0 GBGB2106412.6A GB202106412A GB202106412D0 GB 202106412 D0 GB202106412 D0 GB 202106412D0 GB 202106412 A GB202106412 A GB 202106412A GB 202106412 D0 GB202106412 D0 GB 202106412D0
Authority
GB
United Kingdom
Prior art keywords
distributing microparticles
microparticles
distributing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB2106412.6A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Oxford University Innovation Ltd
Abbott Vascular Devices Ltd
Original Assignee
Biocompatibles Ltd
Oxford University Innovation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biocompatibles Ltd, Oxford University Innovation Ltd filed Critical Biocompatibles Ltd
Priority to GBGB2106412.6A priority Critical patent/GB202106412D0/en
Publication of GB202106412D0 publication Critical patent/GB202106412D0/en
Priority to PCT/GB2022/051126 priority patent/WO2022234266A1/en
Priority to EP22724122.1A priority patent/EP4333978A1/en
Priority to CN202280047576.6A priority patent/CN117677406A/en
Priority to JP2023568113A priority patent/JP2024516453A/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/10—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
    • A61N5/1001—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy using radiation sources introduced into or applied onto the body; brachytherapy
    • A61N5/1007—Arrangements or means for the introduction of sources into the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/1241—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules particles, powders, lyophilizates, adsorbates, e.g. polymers or resins for adsorption or ion-exchange resins
    • A61K51/1244—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules particles, powders, lyophilizates, adsorbates, e.g. polymers or resins for adsorption or ion-exchange resins microparticles or nanoparticles, e.g. polymeric nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0009—Galenical forms characterised by the drug release technique; Application systems commanded by energy involving or responsive to electricity, magnetism or acoustic waves; Galenical aspects of sonophoresis, iontophoresis, electroporation or electroosmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1611—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N7/00—Ultrasound therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/10—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
    • A61N5/1001—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy using radiation sources introduced into or applied onto the body; brachytherapy
    • A61N2005/1019—Sources therefor
    • A61N2005/1024—Seeds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N7/00—Ultrasound therapy
    • A61N2007/0039—Ultrasound therapy using microbubbles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N7/00—Ultrasound therapy
    • A61N2007/0056—Beam shaping elements
    • A61N2007/0065—Concave transducers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N7/00—Ultrasound therapy
    • A61N2007/0086—Beam steering
    • A61N2007/0095—Beam steering by modifying an excitation signal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/10—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
    • A61N5/1001—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy using radiation sources introduced into or applied onto the body; brachytherapy
    • A61N5/1027—Interstitial radiation therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Radiology & Medical Imaging (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Nanotechnology (AREA)
  • Dispersion Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Pathology (AREA)
  • Inorganic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GBGB2106412.6A 2021-05-05 2021-05-05 Distributing microparticles Ceased GB202106412D0 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
GBGB2106412.6A GB202106412D0 (en) 2021-05-05 2021-05-05 Distributing microparticles
PCT/GB2022/051126 WO2022234266A1 (en) 2021-05-05 2022-05-04 Distributing microparticles
EP22724122.1A EP4333978A1 (en) 2021-05-05 2022-05-04 Distributing microparticles
CN202280047576.6A CN117677406A (en) 2021-05-05 2022-05-04 Distributing particles
JP2023568113A JP2024516453A (en) 2021-05-05 2022-05-04 Microparticle Distribution

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB2106412.6A GB202106412D0 (en) 2021-05-05 2021-05-05 Distributing microparticles

Publications (1)

Publication Number Publication Date
GB202106412D0 true GB202106412D0 (en) 2021-06-16

Family

ID=76300972

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB2106412.6A Ceased GB202106412D0 (en) 2021-05-05 2021-05-05 Distributing microparticles

Country Status (5)

Country Link
EP (1) EP4333978A1 (en)
JP (1) JP2024516453A (en)
CN (1) CN117677406A (en)
GB (1) GB202106412D0 (en)
WO (1) WO2022234266A1 (en)

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4789501A (en) 1984-11-19 1988-12-06 The Curators Of The University Of Missouri Glass microspheres
DE3741201A1 (en) * 1987-12-02 1989-06-15 Schering Ag ULTRASONIC PROCESS AND METHOD FOR IMPLEMENTING IT
US6165440A (en) * 1997-07-09 2000-12-26 Board Of Regents, The University Of Texas System Radiation and nanoparticles for enhancement of drug delivery in solid tumors
US6712805B2 (en) * 2001-01-29 2004-03-30 Ultra Sonic Tech Llc Method and apparatus for intradermal incorporation of microparticles containing encapsulated drugs using low frequency ultrasound
US20060058708A1 (en) * 2003-12-24 2006-03-16 Gill Heart Method and apparatus for ultrasonically increasing the transportation of therapeutic substances through tissue
CN1946432B (en) * 2004-03-05 2010-09-29 Xlsci技术公司 Particulate materials and compositions for radio therapy
US8257338B2 (en) * 2006-10-27 2012-09-04 Artenga, Inc. Medical microbubble generation
WO2008029401A1 (en) * 2006-09-05 2008-03-13 Hanoch Kislev Nucleation in liquid, methods of use thereof and methods of generation thereof
US20100178245A1 (en) * 2009-01-13 2010-07-15 Arnsdorf Morton F Biocompatible Microbubbles to Deliver Radioactive Compounds to Tumors, Atherosclerotic Plaques, Joints and Other Targeted Sites
EP2661259A4 (en) * 2011-01-05 2015-04-01 Univ California Acoustically responsive particles with decreased cavitation threshold
WO2017210612A1 (en) * 2016-06-02 2017-12-07 Case Western Reserve University Stabilized crosslinked nanobubbles for diagnostic and therapeutic applications
US10232063B2 (en) * 2014-07-09 2019-03-19 Sirtex Medical Limited Method for treating lung carcinoma
CN107206112B (en) 2014-11-26 2021-01-01 Abk生物医学公司 Radioactive embolization particles
EP4193939A1 (en) * 2015-03-26 2023-06-14 Vensica Medical Ltd. Ultrasonic urinary bladder drug delivery
CA3040016A1 (en) * 2016-09-29 2018-04-05 Sintef Tto As A new drug delivery system for treatment of disease

Also Published As

Publication number Publication date
EP4333978A1 (en) 2024-03-13
JP2024516453A (en) 2024-04-15
CN117677406A (en) 2024-03-08
WO2022234266A1 (en) 2022-11-10

Similar Documents

Publication Publication Date Title
IL289534A (en) Parp1 inhibitors
IL284295A (en) Secure account access
EP4071300C0 (en) Spreader system
ZA202110684B (en) Betavoltaic devices
LT3599836T (en) Feeder
GB2558910B (en) Workstation
GB201908629D0 (en) Distributing data between devices
GB201807801D0 (en) Microparticles
EP3786819C0 (en) Software license distribution
GB201700808D0 (en) Wire dispenser
GB201700553D0 (en) Therapeutic agents
ZA201907529B (en) Feeder
PL3395200T3 (en) Workstation
IL288623A (en) Microparticle compositions comprising saflufenacil
IL287984A (en) Dry microparticles
GB202106412D0 (en) Distributing microparticles
GB2589528B (en) Enabling software distribution
GB2589817B (en) Cranial restructuring devices
GB201918973D0 (en) Particle
GB201906562D0 (en) Devices
FI3710287T3 (en) Spike
GB201717551D0 (en) Antimicrobial agents
GB2585454B (en) Retro-reflective microparticle composition
GB202001737D0 (en) Software distribution
CA191718S (en) Spike

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)